Nonadecane is a long-chain alkane hydrocarbon with the chemical formula C19H40. It is a colorless, odorless, and flammable liquid at room temperature. Nonadecane is found in petroleum and other natural sources. It is also a component of some synthetic fuels and lubricants. Nonadecane is not known to have any significant biological effects. Research on nonadecane primarily focuses on its properties as a fuel and its potential for use in various industrial applications. For example, studies have been conducted on the combustion characteristics of nonadecane in diesel engines. Nonadecane has also been investigated as a potential fuel additive and as a component of synthetic lubricants. The properties of nonadecane, such as its high boiling point and low viscosity, make it suitable for use in these applications.'
nonadecane : A straight-chain alkane with 19 carbon atoms. It has been found as a component of essential oils isolated from Artemisia armeniaca. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]
| Flora | Rank | Flora Definition | Family | Family Definition |
|---|---|---|---|---|
| Artemisia | genus | A plant genus of the family ASTERACEAE with strong-smelling foliage. It is a source of SANTONIN and other cytotoxic TERPENES.[MeSH] | Asteraceae | A large plant family of the order Asterales, subclass Asteridae, class Magnoliopsida. The family is also known as Compositae. Flower petals are joined near the base and stamens alternate with the corolla lobes. The common name of daisy refers to several genera of this family including Aster; CHRYSANTHEMUM; RUDBECKIA; TANACETUM.[MeSH] |
| ID Source | ID |
|---|---|
| PubMed CID | 12401 |
| CHEBI ID | 32927 |
| MeSH ID | M0170723 |
| Synonym |
|---|
| ch3-[ch2]17-ch3 |
| CHEBI:32927 , |
| nonadekan |
| n-nonadecane, 99% |
| nsc-77136 |
| 629-92-5 |
| nonadecane |
| n-nonadecane |
| nsc77136 |
| AN-329/40543671 |
| nonadecane, analytical standard |
| nonadecane, 99% |
| STK032371 |
| 5DFF1F48-853A-4CE2-852C-81C871EF1DA6 |
| AKOS000487358 |
| BMSE000764 |
| QSPL 079 |
| N0282 |
| S0291 |
| nonadecan |
| LMFA11000578 |
| FT-0673031 |
| ai3-36122 |
| unii-nmy21d3y5t |
| einecs 211-116-8 |
| nmy21d3y5t , |
| nsc 77136 |
| hsdb 8349 |
| istd |
| nonadecane, n- |
| LQERIDTXQFOHKA-UHFFFAOYSA-N |
| DTXSID9047170 , |
| mfcd00009012 |
| dtxcid7027170 |
| ch3-(ch2)17-ch3 |
| nonadecane; nsc 77136; n-nonadecane |
| n-nonadecane 10000 microg/ml in dichloromethane |
| nonadecane,(s) |
| Q150911 |
| D91667 |
| AS-56223 |
| nonadecane-d40 98 atom % d |
| Role | Description |
|---|---|
| plant metabolite | Any eukaryotic metabolite produced during a metabolic reaction in plants, the kingdom that include flowering plants, conifers and other gymnosperms. |
| volatile oil component | Any plant metabolite that is found naturally as a component of a volatile oil. |
| [role information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res] | |
| Class | Description |
|---|---|
| long-chain alkane | Any alkane having a chain length of at least 13 carbon atoms. |
| [compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res] | |
| Timeframe | Studies, This Drug (%) | All Drugs % |
|---|---|---|
| pre-1990 | 1 (7.69) | 18.7374 |
| 1990's | 1 (7.69) | 18.2507 |
| 2000's | 5 (38.46) | 29.6817 |
| 2010's | 6 (46.15) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be strong demand-to-supply ratio for research on this compound.
| This Compound (42.55) All Compounds (24.57) |
| Publication Type | This drug (%) | All Drugs (%) |
|---|---|---|
| Trials | 0 (0.00%) | 5.53% |
| Reviews | 0 (0.00%) | 6.00% |
| Case Studies | 0 (0.00%) | 4.05% |
| Observational | 0 (0.00%) | 0.25% |
| Other | 13 (100.00%) | 84.16% |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||